Pleco Therapeutics BV is a Dutch private limited company, established to develop a portfolio of therapies in the field of cancer medicine.
Pleco utilises a global network of academic centres and contract research organisations to test highly-efficient Fixed-Dose Combinations, repurposing existing therapies.
The first Fixed-Dose Combinations are currently being tested in preclinical models.
Pleco utilises a global network of academic centres and contract research organisations to test highly-efficient Fixed-Dose Combinations, repurposing existing therapies.
The first Fixed-Dose Combinations are currently being tested in preclinical models.
Location: Netherlands, Gelderland, Nijmegen
Employees: 1-10
Total raised: $17.19M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Brabant St... | brabant.nl |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.09.2022 | Series A | $17.19M | - |
Mentions in press and media 2
| Date | Title | Description |
| 06.09.2022 | Pleco Therapeutics Closes €17.3M Series A Financing | Pleco Therapeutics, a Nijmegen, The Netherlands-based biopharmaceutical company developing treatments designed to detoxify the cancer micro-environment, raised €17.3M in Series A funding. The round included: €3.6 million in new equity commi... |
| 09.07.2022 | Pleco Therapeutics injected with €17.3 million to boost cancer treatment | Dutch clinical stage biopharmaceutical company Pleco Therapeutics has raised €17.3 million in funding to develop a portfolio of cancer therapies. The Series A round was backed by Oost NL, Hyloris Pharmaceuticals and Netherlands Enterprise A... |